BREAKING
Outdoor Holding Company Q3 2026 Earnings Soar 7% 1 hour ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 3 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 5 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 7 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 9 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 10 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 10 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 11 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 13 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 13 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 1 hour ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 3 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 5 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 7 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 9 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 10 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 10 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 11 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 13 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 13 hours ago
ADVERTISEMENT

ABT Earnings: Key numbers from Abbott Laboratories Q4 financial results

Abbott (NYSE: ABT) today announced its fourth-quarter financial results for the period ended December 31, 2020. Net earnings for the fourth quarter was $2.16 billion, or $1.20 per share, compared to net earnings of $1.04 billion, or $0.59 per share in the fourth quarter of 2019. Total net sales increased 28.7% to $10.7 billion. Abbott […]

January 27, 2021 1 min read

Abbott (NYSE: ABT) today announced its fourth-quarter financial results for the period ended December 31, 2020.

Net earnings for the fourth quarter was $2.16 billion, or $1.20 per share, compared to net earnings of $1.04 billion, or $0.59 per share in the fourth quarter of 2019.

Total net sales increased 28.7% to $10.7 billion.

Abbott shares inched up 1% during the pre-market hours following the earnings announcement.

  • ABBOTT REPORTS THIRD-QUARTER 2020 RESULTS; ACHIEVES STRONG DOUBLE-DIGIT EARNINGS GROWTH AND RAISES GUIDANCE
  • Abbott Laboratories Q2 2020 earnings infographic
  • Abbott Laboratories (ABT) reports in-line earnings for Q3 2019, sales miss view; narrows FY19 outlook

ADVERTISEMENT
ADVERTISEMENT